Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2004 1
2006 1
2007 2
2010 2
2011 2
2012 1
2014 1
2016 4
2017 6
2018 6
2019 3
2020 4
2021 9
2022 10
2023 15
2024 6
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Wolff D, et al. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. N Engl J Med. 2024. PMID: 39292927 Clinical Trial.
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Gur C, Wang SY, Sheban F, Zada M, Li B, Kharouf F, Peleg H, Aamar S, Yalin A, Kirschenbaum D, Braun-Moscovici Y, Jaitin DA, Meir-Salame T, Hagai E, Kragesteen BK, Avni B, Grisariu S, Bornstein C, Shlomi-Loubaton S, David E, Shreberk-Hassidim R, Molho-Pessach V, Amar D, Tzur T, Kuint R, Gross M, Barboy O, Moshe A, Fellus-Alyagor L, Hirsch D, Addadi Y, Erenfeld S, Biton M, Tzemach T, Elazary A, Naparstek Y, Tzemach R, Weiner A, Giladi A, Balbir-Gurman A, Amit I. Gur C, et al. Among authors: avni b. Cell. 2022 Apr 14;185(8):1373-1388.e20. doi: 10.1016/j.cell.2022.03.011. Epub 2022 Apr 4. Cell. 2022. PMID: 35381199 Free PMC article.
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.
Lebel E, Asherie N, Kfir-Erenfeld S, Grisariu S, Avni B, Elias S, Assayag M, Dubnikov-Sharon T, Pick M, Alexander-Shani R, Bessig N, Herr S, Shehadeh A, Ishtay A, Pimienta S, Vainstein V, Zimran E, Cohen Y, Avivi I, Cohen C, Stepensky P, Gatt ME. Lebel E, et al. Among authors: avni b. J Clin Oncol. 2025 Jun 10;43(17):2007-2016. doi: 10.1200/JCO-24-02252. Epub 2024 Dec 9. J Clin Oncol. 2025. PMID: 39653116 Clinical Trial.
Endothelial Activation and Stress Index Score as a Prognostic Factor of Cytokine Release Syndrome in CAR-T Patients - A Retrospective Analysis of Multiple Myeloma and Large B-Cell Lymphoma Cohorts.
Tomasik J, Avni B, Grisariu S, Elias S, Zimran E, Stepensky P, Basak GW. Tomasik J, et al. Among authors: avni b. Arch Immunol Ther Exp (Warsz). 2024 Sep 14;72(1). doi: 10.2478/aite-2024-0018. eCollection 2024 Jan 1. Arch Immunol Ther Exp (Warsz). 2024. PMID: 39277881 Free article.
The DNA methylome of human vascular endothelium and its use in liquid biopsies.
Peretz A, Loyfer N, Piyanzin S, Ochana BL, Neiman D, Magenheim J, Klochendler A, Drawshy Z, Fox-Fisher I, Fridlich O, Moss J, Cohen D, Zemmour H, Cann G, Bredno J, Venn O, Avni B, Alekberli T, Samet Y, Korach A, Wald O, Yutkin V, Izhar U, Pillar N, Grompe M, Fridlender Z, Rokach A, Planer D, Landesberg G, Glaser B, Shemer R, Kaplan T, Dor Y. Peretz A, et al. Among authors: avni b. Med. 2023 Apr 14;4(4):263-281.e4. doi: 10.1016/j.medj.2023.03.006. Med. 2023. PMID: 37060900 Free article.
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.
Kfir-Erenfeld S, Asherie N, Lebel E, Vainstein V, Assayag M, Dubnikov Sharon T, Grisariu S, Avni B, Elias S, Alexander-Shani R, Bessig N, Shehadeh A, Ishtay A, Zelmanovich V, Zimran E, Pick M, Roziner I, Kenett RS, Cohen Y, Avivi I, Cohen CJ, Gatt ME, Stepensky P. Kfir-Erenfeld S, et al. Among authors: avni b. Blood Adv. 2024 Aug 13;8(15):4077-4088. doi: 10.1182/bloodadvances.2024012967. Blood Adv. 2024. PMID: 38768428 Free PMC article. Clinical Trial.
69 results